Charles Schwab’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $5.65M | Buy |
|
|||||
|
2024
Q3 | $1.62M | Buy |
|
|||||
|
2024
Q2 | $1.59M | Buy |
|
|||||
|
2024
Q1 | $1.7M | Buy |
|
|||||
|
2023
Q4 | $1.71M | Buy |
|
|||||
|
2023
Q3 | $1.2M | Buy |
|
|||||
|
2023
Q2 | $756K | Buy |
|
|||||
|
2023
Q1 | $803K | Sell |
|
|||||
|
2022
Q4 | $1.4M | Buy |
|
|||||
|
2022
Q3 | $916K | Buy |
|
|||||
|
2022
Q2 | $342K | Sell |
|
|||||
|
2022
Q1 | $987K | Buy |
|
|||||
|
2021
Q4 | $1.44M | Buy |
|
|||||
|
2021
Q3 | $1.52M | Buy |
|
|||||
|
2021
Q2 | $1.28M | Sell |
|
|||||
|
2021
Q1 | $1.35M | Buy |
|
|||||
|
2020
Q4 | $982K | Buy |
|
|||||
|
2020
Q3 | $781K | Buy |
|